BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19616)

  • 1. Fluorometric determination of nadolol in human serum and urine.
    Ivashkiv E
    J Pharm Sci; 1977 Aug; 66(8):1168-72. PubMed ID: 19616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of orally coadministered nadolol and its deuterated analogue in human serum and urine by gas chromatography with selected-ion monitoring mass spectrometry.
    Cohen AI; Devlin RG; Ivashkiv E; Funke PT; McCormick T
    J Pharm Sci; 1984 Nov; 73(11):1571-5. PubMed ID: 6151597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent.
    Bianchetti G; Ganansia J; Morselli PL
    J Chromatogr; 1979 Aug; 176(1):134-9. PubMed ID: 44712
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids.
    Reiff K
    J Chromatogr; 1987 Jan; 413():355-62. PubMed ID: 2881938
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous quantitative determination of tertatolol and its hydroxylated metabolite in human plasma and urine by gas chromatography-mass spectrometry.
    Efthymiopoulos C; Staveris S; Weber F; Koffel JC; Jung L
    J Chromatogr; 1987 Oct; 421(2):360-6. PubMed ID: 2892852
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.
    Poirier JM; Perez M; Cheymol G; Jaillon P
    J Chromatogr; 1988 Apr; 426(2):431-7. PubMed ID: 2899087
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorimetric determination of nadolol in tablets.
    Ivashikiv E
    J Pharm Sci; 1978 Jul; 67(7):1024-5. PubMed ID: 26790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of serum nadolol levels by GLC--selected ion monitoring mass spectrometry: comparison with a spectrofluorometric method.
    Funke PT; Malley MF; Ivashkiv E; Cohen AI
    J Pharm Sci; 1978 May; 67(5):653-7. PubMed ID: 25332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of the structure of talinolol metabolites in man. Determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum.
    Oertel R; Richter K; Trausch B; Berndt A; Gramatté T; Kirch W
    J Chromatogr B Biomed Appl; 1994 Oct; 660(2):353-63. PubMed ID: 7866526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of tertatolol in biological fluids by gas chromatography-mass spectrometry.
    Staveris S; Blaise P; Efthymiopoulos C; Schneider M; Jamet G; Jung L; Koffel JC
    J Chromatogr; 1985 Apr; 339(1):97-103. PubMed ID: 2862155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. IV. Nadolol diastereomers: demonstration of pharmacokinetic and binding equivalence.
    Piotrovskii VK; Zhirkov YuA ; Metelitsa VI
    J Chromatogr; 1984 Aug; 309(2):421-5. PubMed ID: 6148352
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs.
    Patel BR; Kirschbaum JJ; Poet RB
    J Pharm Sci; 1981 Mar; 70(3):336-8. PubMed ID: 6115047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of carvedilol and ampicillin sodium by first-derivative fluorometry in the presence of human serum albumin.
    Wang HY; Xiao Y; Han J
    Anal Sci; 2005 May; 21(5):537-40. PubMed ID: 15913143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple method for routine determination of betaxolol in blood and urine by automated high-performance liquid chromatography with fluorimetric detection.
    Caqueret H; Bianchetti G
    J Chromatogr; 1984 Nov; 311(1):199-205. PubMed ID: 6151567
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination of nadolol by patients with renal impairment.
    Herrera J; Vukovich RA; Griffith DL
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved determination of betaxolol in biological samples by capillary column gas chromatography.
    Ganansia J; Gillet G; Padovani P; Bianchetti G
    J Chromatogr; 1983 Jun; 275(1):183-8. PubMed ID: 6135703
    [No Abstract]   [Full Text] [Related]  

  • 18. Nadolol binding to human serum proteins.
    Patel L; Johnson A; Turner P
    J Pharm Pharmacol; 1984 Jun; 36(6):414-5. PubMed ID: 6146679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS.
    Buszewski B; Welerowicz T; Tegowska E; Krzemiński TF
    Anal Bioanal Chem; 2009 Jan; 393(1):263-72. PubMed ID: 18781297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of determining nadolol in serum].
    Surmann P
    Arch Pharm (Weinheim); 1980 Dec; 313(12):1052-4. PubMed ID: 6108753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.